Beloved as pets for their hardiness and striking appearance, zebrafish also are making waves in wound care at a new Pittsburgh medical startup.

Co-founded by University of Pittsburgh researchers Michael Tsang and Manush Saydmohammed, Zegenex is focused on developing a product that could help heal chronic wounds both quickly and scar-free.

The aha moment that birthed Zegenex came during a wound experiment in which Tsang and Saydmohammed witnessed zebrafish hearts regenerating after injury. The duo had isolated a molecule within the fish that was responsible for their amazing self-regenerative abilities. When used in the experiment, the molecule increased the animals’ natural healing capabilities, and the two quickly realized the potential applications for wound care, said Tsang, also a professor at Pitt’s School of Medicine.

“Heart regeneration in zebrafish is somewhat unique. It's very different from humans. … But we think that we can adapt this into a wound-healing activity in human patients,” he said.

Advertise with us

One of the first applications that came to mind was diabetic foot ulcers, which are notoriously hard to heal for many patients. The ulcers can sometimes take 12 weeks or more to mend and are an ideal entry point for infection-causing bacteria, like methicillin-resistant Staphylococcus aureus (MRSA). Tsang explained that there are few options for patients suffering from these types of ulcers, and treatment can be very costly.

An estimated 300 million people worldwide will suffer from diabetes by 2025, according to the National Institutes of Health (NIH). The Centers for Disease Control estimated that, in 2010, there were 25.8 million Americans, or 8.3% of the adult population, with diabetes.

Wound healing is difficult in diabetes primarily because high blood sugar levels damage blood vessels, leading to poor circulation and reduced blood flow to the wound site, which deprives it of the necessary oxygen and nutrients to heal properly. In addition, this is further compounded by nerve damage — called neuropathy — which can impair the body's ability to sense injuries and initiate the healing process.

The NIH study said that mortality rates for diabetic patients with ulcers is roughly double that of those who do not suffer from them. It also noted that up to 85% of diabetes‐related lower extremity amputations are preceded by foot ulcers. Diabetic patients are 10 times more likely to require amputations than non-diabetic patients.

“The cost of wound care is enormous,” Saydmohammed said. Adults over the age of 50 have a high likelihood of developing non-healing wounds at some point in their lives. For those who do not have health insurance or if the wounds worsen, those patients end up in the emergency room, driving up health care costs, he said.

Advertise with us
University of Pittsburgh research scientist Manush Saydmohammed, left, and Pitt School of Medicine professor Michael Tsang are studying the potential for wound care treatments via the unassuming zebrafish. (Aimee Obidzinski / University of Pittsburgh)

More wound-care applications

“Our experiments have suggested that [burns, lacerations and similar wounds] can heal faster and also [the treatment] can resolve scars, suggesting that this can also have potential applications even in the cosmetic industry,” Saydmohammed said.

The duo envisions first introducing a viable commercial product — likely in the form of creams, sprays and a biomedical patch that dissolves into the skin — to veterinary hospitals, possibly as soon as 2026.

For humans, the regulatory and clinical trial processes take much longer, and it could be five or more years before the products are approved for use, Saydmohammed said.

But for those products to hit the market, the duo needs to reel in investors who believe in their research’s potential.

“So far, all our experiments were supported by federally funded research,” Saydmohammed said. “When it comes to a company, we have to raise external funding from angel investors. Right now, the company is looking to raise a million dollars initially to complete the preclinical experiments in large animal models so that we can talk to the FDA.”

Advertise with us

Pitt, via its innovation and entrepreneurship office, guided Saydmohammed and Tsang on filing an invention disclosure to protect their intellectual property, and the two partnered with the university’s Innovation Institute to move forward with filing a patent, according to Pitt. They found additional support from the NIH, and Zegenex was selected to be part of Pitt’s LifeX incubator this fall. The life sciences capital growth program provided mentorship and resources to help the start-up transform its laboratory discoveries into a commercial product.

The amazing zebrafish 

According to the NIH, zebrafish are tropical fresh-water fish in the minnow family. In the wild, they are found in rivers and ponds of India; however, they are now often available in pet shops. The name “zebrafish” comes from the horizontal blue stripes on each side of their bodies.

While mammalian research subjects such as mice and monkeys are evolutionarily more similar to humans, zebrafish provide several advantages over their furry competitors.

Humans and zebrafish share 70%of the same genes, and 84% of human genes known to be associated with human disease have a counterpart in zebrafish, according to researchers at Penn State University. Major organs and tissues are also common between the two species.

One important advantage of zebrafish is that the adults are small and prefer to be housed in large groups, or “shoals.” As a result, they require much less space and are cheaper to maintain than mice. Another advantage is that adult zebrafish breed readily (approximately every 10 days) and can produce as many as 50 to 300 eggs at a time.

Advertise with us

There are records of zebrafish being used as research subjects since the 1950s, but they gained popularity in the 1990s.

Tsang said he first worked with zebrafish in the late 1990s during his postdoctoral research at the NIH.

“We can study the embryo developing from the one-cell stage all the way to the adult. We can follow that development under the microscope. The other benefit or advantage of zebrafish is that the genes that make them function, make them what they are, are not that far apart from us. And so they have very similar biology to a lot of things that we do. And so that makes them perfect for drug screens.”